Contrast-enhanced dynamic and diffusion-weighted magnetic resonance imaging at 3.0 T to assess early-stage nasopharyngeal carcinoma

Ni,Liangping; Liu,Ying

doi:10.3892/ol.2018.7948

Contrast-enhanced dynamic and diffusion-weighted magnetic resonance imaging at 3.0 T to assess early-stage nasopharyngeal carcinoma

Authors:
- Liangping Ni
- Ying Liu
View Affiliations

Affiliations: Department of Radiology, Anhui Medical University Affiliated Anhui Provincial Hospital, Hefei, Anhui 230001, P.R. China
Published online on: February 5, 2018 https://doi.org/10.3892/ol.2018.7948
Pages: 5294-5300

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to assess early-stage nasopharyngeal carcinoma (NPC) with dynamic contrast-enhanced magnetic resonance imaging (DCE‑MRI) and diffusion‑weighted imaging (DWI) at 3.0 T. A total of 44 patients newly diagnosed with NPC were included in the present study. All patients underwent MR examination at 3.0 T using DCE‑MRI and DWI. The volume transfer constant (Ktrans), flux rate constant between extravascular extracellular space and plasma (Kep), the volume of extravascular extracellular space per unit volume of tissue (Ve) and the apparent diffusion coefficient (ADC) of tumours were investigated. Furthermore, the correlation between clinical stages and ADC value and Ktrans were analysed. The diagnostic accuracy of Ktrans and ADC were estimated using receiver operating characteristic curves. NPC stage correlated positively with Ktrans and negatively with ADC values. Additionally, tumour Ktrans negatively correlated with ADC value. The sensitivity and accuracy of combined Ktrans and ADC in distinguishing between stage II and stage III and stage III and IV were higher than the values of either measurement used separately. The present study suggested that Ktrans and ADC derived from DCE‑MRI and DWI may be useful to detect stage early NPC accurately. Ktrans and ADC in combination were superior than either alone.

View Figures

View References

1	Lee AW, Lin JC and Ng WT: Current management of nasopharyngeal cancer. Semin Radiat Oncol. 22:233–244. 2012. View Article : Google Scholar : PubMed/NCBI
2	Boscolo-Rizzo P, Tirelli G, Mantovani M, Baggio V, Lupato V, Spinato G, Gava A and Da Mosto MC: Non-endemic locoregional advanced nasopharyngeal carcinoma: Long-term outcome after induction plus concurrent chemoradiotherapy in everyday clinical practice. Eur Arch Otorhinolaryngol. 272:3491–3498. 2015. View Article : Google Scholar : PubMed/NCBI
3	Chen Y, Liu X, Zheng D, Xu L, Hong L, Xu Y and Pan J: Diffusion-weighted magnetic resonance imaging for early response assessment of chemoradiotherapy in patients with nasopharyngeal carcinoma. Magn Reson Imaging. 32:630–637. 2014. View Article : Google Scholar : PubMed/NCBI
4	Yi JL, Gao L, Huang XD, Li SY, Luo JW, Cai WM, Xiao JP and Xu GZ: Nasopharyngeal carcinoma treated by radical radiotherapy alone: Ten-year experience of a single institution. Int J Radiat Oncol Biol Phys. 65:161–168. 2006. View Article : Google Scholar : PubMed/NCBI
5	Spratt DE and Lee N: Current and emerging treatment options for nasopharyngeal number carcinoma. Onco Targets Ther. 5:297–308. 2012.PubMed/NCBI
6	Türkbey B, Thomasson D, Pang Y, Bernardo M and Choyke PL: The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment. Diagn Interv Radiol. 16:186–192. 2010.PubMed/NCBI
7	Pan J, Zang L, Zhang Y, Hong J, Yao Y, Zou C, Zhang L and Chen Y: Early changes in apparent diffusion coefficients predict radiosensitivity of human nasopharyngeal carcinoma xenografts. Laryngoscope. 122:839–843. 2012. View Article : Google Scholar : PubMed/NCBI
8	Huang B, Wong CS, Whitcher B, Kwong DL, Lai V, Chan Q and Khong PL: Dynamic contrast enhanced magnetic resonance imaging for characterising nasopharyngeal carcinoma: Comparison of semiquantitative and quantitative parameters and correlation with tumour stage. Eur Radiol. 23:1495–1502. 2013. View Article : Google Scholar : PubMed/NCBI
9	Zheng D, Chen Y, Chen Y, Xu L, Chen W, Yao Y, Du Z, Deng X and Chan Q: Dynamic contrast-enhanced MRI of nasopharyngeal carcinoma: A preliminary study of the correlations between quantitative parameters and clinical stage. J Magn Reson Imaging. 39:940–948. 2014. View Article : Google Scholar : PubMed/NCBI
10	Abdel Razek AA and Kamal E: Nasopharyngeal carcinoma: Correlation of apparent diffusion coefficient value with prognostic parameters. Radiol Med. 118:534–539. 2013. View Article : Google Scholar : PubMed/NCBI
11	Vandecaveye V, Dirix P, De Keyzer F, de Beeck KO, Vander Poorten V, Roebben I, Nuyts S and Hermans R: Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma. Eur Radiol. 20:1703–1714. 2010. View Article : Google Scholar : PubMed/NCBI
12	Kim S, Loevner LA, Quon H, Kilger A, Sherman E, Weinstein G, Chalian A and Poptani H: Prediction of response to chemoradiation therapy in squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging. AJNR Am J Neuroradiol. 31:262–268. 2010. View Article : Google Scholar : PubMed/NCBI
13	Powell C, Schmidt M, Borri M, Koh DM, Partridge M, Riddell A, Cook G, Bhide SA, Nutting CM, Harrington KJ and Newbold KL: Changes in functional imaging parameters following induction chemotherapy have important implications for individualised patient-based treatment regimens for advanced head and neck cancer. Radiother Oncol. 106:112–117. 2013. View Article : Google Scholar : PubMed/NCBI
14	Zhou G, Chen X, Zhang J, Zhu J, Zong G and Wang Z: Contrast-enhanced dynamic and diffusion-weighted MR imaging at 3.0T to assess aggressiveness of bladder cancer. Eur J Radiol. 83:2013–2018. 2014. View Article : Google Scholar : PubMed/NCBI
15	Kul S, Cansu A, Alhan E, Dinc H, Gunes G and Reis A: Contribution of diffusion weighted imaging to dynamic contrast-enhanced MRI in the characterization of breast tumors. AJR Am J Roentgenol. 196:210–217. 2011. View Article : Google Scholar : PubMed/NCBI
16	Hong J, Yao Y, Zhang Y, Tang T, Zhang H, Bao D, Chen Y and Pan J: Value of magnetic resonance diffusion-weighted imaging for the prediction of radio sensitivity in nasopharyngeal carcinoma. Otolaryngol Head Neck Surg. 149:707–713. 2013. View Article : Google Scholar : PubMed/NCBI
17	Fong D, Bhatia KS, Yeung D and King AD: Diagnostic accuracy of diffusion weighted MR imaging for nasopharyngeal carcinoma, head and neck lymphoma and squamous cell carcinoma at the primary site. Oral Oncol. 46:603–606. 2010. View Article : Google Scholar : PubMed/NCBI
18	Li H, Liu XW, Geng ZJ, Wang DL and Xie CM: Diffusion-weighted imaging to differentiate metastatic from non-metastatic retropharyngeal lymph nodes in nasopharyngeal carcinoma. Dentomaxillofac Radiol. 44:201401262015. View Article : Google Scholar : PubMed/NCBI
19	Kobayashi S, Koga F, Kajino K, Yoshita S, Ishii C, Tanaka H, Saito K, Masuda H, Fujii Y, Yamada T and Kihara K: Apparent diffusion coefficient value reflects invasive and proliferative potential of bladder cancer. J Magn Reson Imaging. 39:172–178. 2014. View Article : Google Scholar : PubMed/NCBI
20	Langer DL, van der Kwast TH, Evans AJ, Plotkin A, Trachtenberg J, Wilson BC and Haider MA: Prostate tissue composition and MR measurements: Investigating the relationships between ADC, T2, K^trans, v_e and corresponding histologic features. Radiology. 255:485–494. 2010. View Article : Google Scholar : PubMed/NCBI
21	Lee J, Choi SH, Kim JH, Sohn CH, Lee S and Jeong J: Glioma grading using apparent diffusion coefficient map: Application of histogram analysis based on automatic segmentation. NMR Biomed. 27:1046–1052. 2014. View Article : Google Scholar : PubMed/NCBI
22	Guo AC, Cummings TJ, Dash RC and Provenzale JM: Lymphomas and high-grade astrocytomas: Comparison of water diffusibility and histologic characteristics. Radiology. 224:177–183. 2002. View Article : Google Scholar : PubMed/NCBI
23	Yao WW, Zhang H, Ding B, Fu T, Jia H, Pang L, Song L, Xu W, Song Q, Chen K and Pan Z: Rectal Cancer: 3D dynamic contrast-enhanced MRI; correlation with microvascular density and clinicopathological features. Radiol Med. 116:366–374. 2011. View Article : Google Scholar : PubMed/NCBI
24	Law M, Oh S, Babb JS, Wang E, Inglese M, Zagzag D, Knopp EA and Johnson G: Low-grade gliomas: Dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging prediction of patient clinical response. Radiology. 238:658–667. 2006. View Article : Google Scholar : PubMed/NCBI
25	Möbius C, Freire J, Becker I, Feith M, Brücher BL, Hennig M, Siewert JR and Stein HJ: VEGF-C expression in squamous cell carcinoma and adenocarcinoma of the esophagus. World J Surg. 31:1768–1772. 2007. View Article : Google Scholar : PubMed/NCBI
26	El Khouli RH, Macura KJ, Kamel IR, Jacobs MA and Bluemke DA: 3-T dynamic contrast-enhanced MRI of the breast: Pharmacokinetic parameters versus conventional kinetic curve analysis. AJR Am J Roentgenol. 197:1498–1505. 2011. View Article : Google Scholar : PubMed/NCBI
27	Arevalo-Perez J, Peck KK, Young RJ, Holodny AI, Karimi S and Lyo JK: Dynamic contrast-enhanced perfusion MRI and diffusion-weighted imaging in grading of gliomas. J Neuroimaging. 25:792–798. 2015. View Article : Google Scholar : PubMed/NCBI
28	Woodhams R, Matsunaga K, Kan S, Hata H, Ozaki M, Iwabuchi K, Kuranami M, Watanabe M and Hayakawa K: ADC mapping of benign and malignant breast tumors. Magn Reson Med Sci. 4:35–42. 2005. View Article : Google Scholar : PubMed/NCBI